Triad Investment Management Takes Position in Hercules Capital, Inc. $HTGC

Triad Investment Management acquired a new position in Hercules Capital, Inc. (NYSE:HTGC) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 104,063 shares of the financial services provider’s stock, valued at approximately $1,958,000. Hercules Capital accounts for approximately 2.0% of Triad Investment Management’s investment portfolio, making the stock its 21st largest position.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Centaurus Financial Inc. increased its position in Hercules Capital by 1.8% in the 3rd quarter. Centaurus Financial Inc. now owns 37,819 shares of the financial services provider’s stock worth $715,000 after buying an additional 675 shares during the period. Allworth Financial LP boosted its position in shares of Hercules Capital by 11.4% in the third quarter. Allworth Financial LP now owns 6,652 shares of the financial services provider’s stock valued at $126,000 after acquiring an additional 680 shares during the period. Foundations Investment Advisors LLC grew its stake in shares of Hercules Capital by 2.9% in the third quarter. Foundations Investment Advisors LLC now owns 25,902 shares of the financial services provider’s stock worth $490,000 after acquiring an additional 732 shares during the last quarter. Dakota Wealth Management increased its position in Hercules Capital by 1.9% during the third quarter. Dakota Wealth Management now owns 38,720 shares of the financial services provider’s stock worth $732,000 after acquiring an additional 735 shares during the period. Finally, Cornerstone Wealth Management LLC raised its stake in Hercules Capital by 3.6% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 21,176 shares of the financial services provider’s stock valued at $400,000 after purchasing an additional 736 shares during the last quarter. Institutional investors and hedge funds own 19.69% of the company’s stock.

Hercules Capital News Summary

Here are the key news stories impacting Hercules Capital this week:

• Positive Sentiment: There was a brief intraday bounce noted recently, showing the stock can rally on short‑term flows despite pressure — a sign traders can create short‑term moves even as headlines turn negative. Hercules Capital (HTGC) Advances
• Neutral Sentiment: Valuation and investor‑note pieces are re‑examining whether current prices reflect long‑term value vs. near‑term risk; these analyses are useful for longer‑term shareholders weighing whether recent weakness is a buying opportunity or warning sign. Is It Time To Reassess Hercules Capital?
• Negative Sentiment: Hagens Berman filed a securities class action after the Hunterbrook report; the complaint cites alleged copying of Google Ventures sourcing, misstated marks and questions about PIK loans — allegations that directly target the firm’s underwriting and disclosure practices. Hagens Berman Class Action Notice
• Negative Sentiment: Multiple plaintiff firms (Glancy, Faruqi, Pomerantz, Rosen, Levi & Korsinsky, Robbins, Schall, etc.) are actively soliciting lead plaintiffs and reminding investors of a May 19, 2026 deadline — the concentrated legal solicitations amplify headline risk and the probability of expensive, drawn‑out litigation. Glancy Lead Plaintiff Notice
• Negative Sentiment: Some firms quantify near‑term investor damages (Levi & Korsinsky citing a $1.22 per‑share decline after the corrective report) and analysts/columnists warn that any software‑sector markdowns or loan revaluations could turn the apparent valuation discount into realized losses. That elevates downside risk for holders. Levi & Korsinsky Investor Alert

Insider Transactions at Hercules Capital

In related news, CEO Scott Bluestein acquired 30,000 shares of the stock in a transaction dated Tuesday, February 24th. The shares were bought at an average cost of $15.08 per share, for a total transaction of $452,400.00. Following the purchase, the chief executive officer owned 2,509,379 shares in the company, valued at approximately $37,841,435.32. This trade represents a 1.21% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Nikos Theodosopoulos bought 6,165 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was bought at an average cost of $15.93 per share, with a total value of $98,208.45. Following the completion of the acquisition, the director owned 18,923 shares in the company, valued at $301,443.39. This represents a 48.32% increase in their position. The SEC filing for this purchase provides additional information. Over the last three months, insiders have acquired 117,015 shares of company stock valued at $1,749,620. Corporate insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on HTGC shares. Capital One Financial set a $19.75 price target on shares of Hercules Capital in a report on Monday, December 15th. Keefe, Bruyette & Woods cut their price objective on shares of Hercules Capital from $20.00 to $19.00 and set an “outperform” rating for the company in a research report on Friday, February 13th. Wall Street Zen cut shares of Hercules Capital from a “buy” rating to a “hold” rating in a research note on Saturday, December 20th. Weiss Ratings downgraded Hercules Capital from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Finally, Wells Fargo & Company lowered their price target on Hercules Capital from $18.00 to $17.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $18.71.

Hercules Capital Stock Down 1.5%

HTGC opened at $14.55 on Thursday. Hercules Capital, Inc. has a fifty-two week low of $13.70 and a fifty-two week high of $19.67. The company has a debt-to-equity ratio of 1.03, a current ratio of 1.48 and a quick ratio of 1.48. The firm’s fifty day moving average price is $15.68 and its two-hundred day moving average price is $17.38. The company has a market capitalization of $2.67 billion, a P/E ratio of 7.95 and a beta of 0.83.

Hercules Capital (NYSE:HTGC) last announced its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.48 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.48. The company had revenue of $133.25 million during the quarter, compared to analysts’ expectations of $141.57 million. Hercules Capital had a net margin of 63.80% and a return on equity of 15.97%. During the same quarter in the prior year, the company posted $0.49 EPS. On average, analysts anticipate that Hercules Capital, Inc. will post 1.96 EPS for the current year.

Hercules Capital Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 4th. Investors of record on Wednesday, February 25th were given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Wednesday, February 25th. Hercules Capital’s dividend payout ratio is 87.43%.

About Hercules Capital

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.